• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Vitamins and Dietary Supplements in Belgium Product Image

Vitamins and Dietary Supplements in Belgium

  • ID: 313088
  • June 2014
  • Region: Europe, Belgium
  • 46 Pages
  • Euromonitor International

FEATURED COMPANIES

  • Arkopharma NV SA
  • Biodiphar NV SA
  • Centrapharm NV SA
  • Madaus Pharma NV SA
  • Omega Pharma SA
  • Sanofi-Synthélabo NV
  • MORE

Most players did not expect such a fate for vitamins and dietary supplements in 2013. In 2012 the category was anticipated to take a back seat in 2013. From 14 December 2012, the regulatory environment for vitamins and dietary supplements was set to become stricter, with new regulation of health claims. Yet during the whole of 2012, players were on the home straight in terms of conforming to the new EFSA (European Food Safety Authority) regulation, and vitamins and dietary supplements still...

The Vitamins and Dietary Supplements in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2009-2013, allowing you to identify the sectors driving growth. Forecasts to 2018 illustrate how the market is set to change.

Product coverage: Dietary Supplements, Paediatric Vitamins and Dietary Supplements, Tonics and Bottled Nutritive Drinks, Vitamins.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Vitamins and Dietary Supplements market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arkopharma NV SA
  • Biodiphar NV SA
  • Centrapharm NV SA
  • Madaus Pharma NV SA
  • Omega Pharma SA
  • Sanofi-Synthélabo NV
  • MORE

VITAMINS AND DIETARY SUPPLEMENTS IN BELGIUM

June 2014

LIST OF CONTENTS AND TABLES

Headlines
Trends
Vitamins
Dietary Supplements
Competitive Landscape
Prospects
Category Data
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2013
Summary 2 Multivitamins: Brand Ranking by Positioning 2013
Category Data
Table 1 Sales of Vitamins and Dietary Supplements by Category: Value 2008-2013
Table 2 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2008-2013
Table 3 Sales of Multivitamins by Positioning: % Value 2008-2013
Table 4 Sales of Dietary Supplements by Positioning: % Value 2008-2013
Table 5 NBO Company Shares of Vitamins and Dietary Supplements: % Value 2009-2013
Table 6 LBN Brand Shares of Vitamins and Dietary Supplements: % Value 2010-2013
Table 7 LBN Brand Shares of Vitamins: % Value 2010-2013
Table 8 LBN Brand Shares of Dietary Supplements: % Value 2010-2013
Table 9 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2013-2018
Table 10 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2013-2018
Laboratoria Qualiphar NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 3 Laboratoria Qualiphar NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 4 Laboratoria Qualiphar NV SA: Competitive Position 2013
Merck Consumer Healthcare Belgium NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 5 Merck Consumer Healthcare Belgium NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 6 Merck Consumer Healthcare Belgium NV SA: Competitive Position 2013
Upsa Médica NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 7 UPSA Médica: Operational Indicators
Company Background
Production
Summary 8 UPSA Médica: Production Statistics 2013
Competitive Positioning
Summary 9 UPSA Médica: Competitive Position 2013
Executive Summary
Unexpected Respite in 2013
Efsa Regulation Is More frightening than Actually causing Harm...for the Moment
Belgian Players Often Fare Better Than Multinationals
No Changes in Distribution: Still Under the Control of Chemists/pharmacies
Mixed Picture for Consumer Health
Key Trends and Developments
Unfavourable Economic Context Slightly Weighs on Consumer Health
Efsa Adds Another Layer of Constraints, But Does Not Kill the Non-otc Market
Related Markets Still Influence Some Categories
Belgium Remains A Puzzle for Many Multinationals
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services: Value 2008-2013
Table 12 Life Expectancy at Birth 2008-2013
Market Data
Table 13 Sales of Consumer Health by Category: Value 2008-2013
Table 14 Sales of Consumer Health by Category: % Value Growth 2008-2013
Table 15 NBO Company Shares of Consumer Health: % Value 2009-2013
Table 16 LBN Brand Shares of Consumer Health: % Value 2010-2013
Table 17 Penetration of Private Label in Consumer Health by Category: % Value 2008-2013
Table 18 Distribution of Consumer Health by Format: % Value 2008-2013
Table 19 Distribution of Consumer Health by Format and Category: % Value 2013
Table 20 Forecast Sales of Consumer Health by Category: Value 2013-2018
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2013-2018
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Alternative Therapy
Switches
Summary 10 OTC: Switches 2011-2013
Sources
Summary 11 Research Sources

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arkopharma NV SA
  • Biodiphar NV SA
  • Centrapharm NV SA
  • Madaus Pharma NV SA
  • Omega Pharma SA
  • Sanofi-Synthélabo NV
  • MORE

Slightly better growth expected
After two years of non-negligible growth, OTC healthcare might perform better up to 2010 than during the historic period thanks to the diminishing effects of government policy, the development of more segmented and convenient products and the ageing population.

Analgesics, cough, cold and allergy remedies, digestive remedies and even medicated skin care will enjoy modest but positive growth despite the expected upsurge of private label products. Deregulated dietary supplements will remain the strongest growth driver thanks to manufacturer creativity in developing products to match the rising demand for preventive treatments and functional substances.

Note: Product cover images may vary from those shown

Companies Mentioned Include:
- Janssen-Cilag NV
- Synthélabo Belgium SA
- Boehringer Ingelheim NV SA
- Novartis Consumer Health SA NV
- Roche NV SA
- Omega Pharma SA
- Procter & Gamble Eurocor NV SA
- Merck Sharp & Dohme BV
- Pfizer Consumer Healthcare NV SA
- Boots Healthcare NV
- Glaxo Wellcome Belgium NV
- UPSA Médica NV SA
- Aventis Pharma NV SA
- Zambon NV SA
- Bayer NV SA
- Beiersdorf NV SA
- Ricola AG
- Menarini Benelux
- Viatris GmbH & Co KG
- Norgine NV SA
- Laboratoria Qualiphar NV SA
- Sanofi-Synthélabo NV
- Biodiphar NV SA
- Centrapharm NV SA
- Will Pharma NV SA
- Bio-Fyt Pharma NV
- Whitehall Benelux SA
- Arkopharma NV SA
- Fournier Pharma NV SA
- Biodynamics NV
- Ortis, Laboratoires
- Madaus Pharma NV SA

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos